Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Elicio Therapeutics, Inc.
Market Cap
$36.61M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$36.37M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$36.32M
Operating Margin
-149.78%
TTM Avg
-148.02%
3Y Avg
-141.74%
5Y Avg
-107.90%
Market Cap
$35.89M
Operating Margin
-6.58%
TTM Avg
-2.44%
3Y Avg
-1.06%
5Y Avg
0.55%
Market Cap
$37.67M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-324.45%
Market Cap
$38.34M
Operating Margin
1.17%
TTM Avg
-3.67%
3Y Avg
-2.94%
5Y Avg
-1.63%
Market Cap
$38.41M
Operating Margin
0.00%
TTM Avg
-13830.82%
3Y Avg
-69500.82%
5Y Avg
-46675.05%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elicio Therapeutics, Inc. (ELTX) | $36.61M | 0.00% | 0.00% | 0.00% | 0.00% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $36.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Elutia Inc (ELUT)vs › | $36.32M | -149.78% | -148.02% | -141.74% | -107.90% |
| HeartBeam, Inc. (BEAT)vs › | $36.31M | 0.00% | 0.00% | 0.00% | 0.00% |
| DocGo Inc. (DCGO)vs › | $36.05M | -27.67% | -11.51% | -3.91% | -4.42% |
| Accuray Incorporated (ARAY)vs › | $35.89M | -6.58% | -2.44% | -1.06% | 0.55% |
| Edesa Biotech, Inc. (EDSA)vs › | $37.67M | 0.00% | 0.00% | 0.00% | -324.45% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.34M | 1.17% | -3.67% | -2.94% | -1.63% |
| Incannex Healthcare Limited (IXHL)vs › | $38.41M | 0.00% | -13830.82% | -69500.82% | -46675.05% |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.52M | 0.00% | 0.00% | 0.00% | -1396.17% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | -878.94% |
| 2021-12-31 | 56.41% |
| 2021-09-30 | -1079.32% |
| 2021-06-30 | -3378.52% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | -3017.43% |
| 2020-09-30 | -1400.85% |
| 2020-06-30 | -2368.86% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | -2039.22% |
